HIV Malignancy Specimens for Research at No Charge
The latest from the ACSR, published in Biopreservation and Biobanking! Access the entire manuscript here: https://www.liebertpub.com/doi/epdf/10.1177/19475535251363861
Favorable research results from the PURPOSE 1 trial (South Africa and Uganda) have been published in the New England Journal of Medicine and presented at IAS 2024 in Munich, use …
We are thrilled to announce ACSR’s highly valued relationship with Proscia®. Read the full release below for more on how enterprise digital pathology thru Proscia Concentriq is helping the ACSR …
Read “Tackling cancer globally requires research commitments in LMICs”, the latest Worldview Editorial in Nature written by Dr. Satish Gopal, Director of the National Cancer Institute’s Center for Global Health. …
Congratulations ACSR authors & friends on the long awaited “The Persistence of #HIV Diversity, Transcription, and Nef Protein in Kaposi Sarcoma Tumors during Antiretroviral Therapy. https://mdpi.com/1999-4915/14/12/2774 Nolan DJ, Rose R, …
New off the press by the ACSR’s Dr. Jeffrey Bethony and colleagues from George Washington University, Scripps Research, the Fred Hutchinson Cancer Center, the National Institutes of Health and other …
Results from the successful Anal Cancer/HSIL Outcomes Research (ANCHOR) study were published June 16 in the New England Journal of Medicine. This clinical trial of people living with HIV has …
In this opinion piece featured in JAMA, Lawrence Corey, Russell Corbett-Detig, Chris Beyrer write about the exceedingly harmful effects that SARS-CoV-2 variants and HIV has had on the other. The …
Use of stem cells for research has not be conducted without its share of controversy. New research using a new transplant method involving umbilical cord blood, presented at this year’s …
Our recent experiences with the coronavirus pandemic have demonstrated that new mutations in viral genetic sequences can have significant impacts on the virus’s transmissibility and the degrees of illness it …